Early FDA Feedback with Type D Meetings
The Premier Consulting Blog
OCTOBER 1, 2023
PDUFA VII will be in effect from fiscal year 2023 through fiscal year 2027. It is the sixth reauthorization of PDUFA that provides the FDA with necessary resources and includes provisions to increase the efficiency of the drug development process. Check out our previous blog post to learn more about changes that came in PDUFA VII.
Let's personalize your content